This Article Full Text Full Text (PDF) All Versions of this Article: 45/5/887    most recent 01.HYP.0000163460.07639.3fv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kario, K. Articles by Shimada, K. Search for Related Content PubMed PubMed Citation Articles by Kario, K. Articles by Shimada, K. Related Collections Primary prevention Cerebrovascular disease/stroke Type 2 diabetes CT and MRI Brain Circulation and Metabolism Other imaging Risk Factors for Stroke

(Hypertension. 2005;45:887.)
© 2005 American Heart Association, Inc.

Original Articles

Diabetic Brain Damage in Hypertension

Role of Renin-Angiotensin System

Kazuomi Kario; Joji Ishikawa; Satoshi Hoshide; Yoshio Matsui; Masato Morinari; Kazuo Eguchi; Shizukiyo Ishikawa; Kazuyuki Shimada

From the Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical School, Tochigi, Japan.

Correspondence to Kazuomi Kario, MD, FACP, FACC, FAHA, Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi, Kawachi, Tochigi 329-0498, Japan. E-mail kkario{at}jichi.ac.jp

Diabetes and hypertension are potent risk factors for cerebrovascular disease. We studied the effects of an angiotensin II type 1 receptor blockade (ARB) on brain damage in hypertensives in relation to diabetes. We studied cerebral metabolism (by proton magnetic resonance spectroscopy) and hemodynamics (by phase-contrast magnetic resonance angiography) before and 3 to 4 months after candesartan therapy in 20 diabetic hypertensives (DHTs) and 20 matched nondiabetic hypertensives (HTs). Silent multiple cerebral infarcts detected by brain MRI were more common in DHTs than in HTs (50% versus 25%). Cerebral N-acetyl aspartate (NAA; an indicator of functional neuronal mass) was lower in DHTs than in HTs (8.35 versus 9.58 mmol/kg; P=0.007). Baseline quantitative volume flow in the internal carotid arteries (ICAs) and the middle cerebral arteries (MCAs) was comparable between the 2 groups, whereas cerebrovascular reserve (CVR) assessed using acetazolamide (a cerebral arteriolar dilator) in ICAs (25% versus 35%; P=0.03) and MCAs (20% versus 31%; P=0.01) was lower in DHTs than in HTs. These baseline CVR and NAA values of DHT group were lower than those of 12 matched normotensives (CVR: 44% for ICA; 41% for MCA; NAA: 10.5 mmol/kg; all P<0.005). After candesartan therapy, CVR in ICAs and MCAs was significantly increased (P=0.001) independently of the reduction of the 24-hour blood pressure level, whereas the cerebral NAA level did not change. In conclusion, brain damage is advanced in DHTs. ARB partly improved the impaired cerebral microvascular function in DHTs.

Key Words: metabolism • circulation • receptors, angiotensin • blood pressure

This article has been cited by other articles:

				D. Last, D. C. Alsop, A. M. Abduljalil, R. P. Marquis, C. de Bazelaire, K. Hu, J. Cavallerano, and V. Novak Global and Regional Effects of Type 2 Diabetes on Brain Tissue Volumes and Cerebral Vasoreactivity Diabetes Care, May 1, 2007; 30(5): 1193 - 1199. [Abstract] [Full Text] [PDF]

				B. van Harten, F.-E. de Leeuw, H. C. Weinstein, P. Scheltens, and G. J. Biessels Brain Imaging in Patients With Diabetes: A systematic review. Diabetes Care, November 1, 2006; 29(11): 2539 - 2548. [Full Text] [PDF]

				K. Toyoda, Y. Okada, S. Fujimoto, N. Hagiwara, K. Nakachi, T. Kitazono, S. Ibayashi, and M. Iida Blood Pressure Changes During the Initial Week After Different Subtypes of Ischemic Stroke Stroke, October 1, 2006; 37(10): 2637 - 2639. [Abstract] [Full Text] [PDF]

				V. Novak, D. Last, D. C. Alsop, A. M. Abduljalil, K. Hu, L. Lepicovsky, J. Cavallerano, and L. A. Lipsitz Cerebral Blood Flow Velocity and Periventricular White Matter Hyperintensities in Type 2 Diabetes Diabetes Care, July 1, 2006; 29(7): 1529 - 1534. [Abstract] [Full Text] [PDF]